Can S.E.T. Aid Zimmer (ZBH) Q1 Earnings Despite Supply Woes?
Zacks Investment Research | Apr 15, 2018 10:44PM ET
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is set to report first-quarter 2018 results on Apr 26, before the markets open.
Last quarter, the company posted earnings in line with the Zacks Consensus Estimate. However, Zimmer Biomet missed the consensus mark in two of the preceding four quarters, the average being 0.29%. .
Let’s take a look at how things are shaping up prior to this announcement.
Key Catalysts
The company is expected to report strong topline numbers within its S.E.T. (Surgical, Sports Medicine, Foot and Ankle, Extremities and Trauma) arm in the to-be-reported period. Last quarter, revenues at S.E.T. were driven by solid quarterly sales of the company’s surgical portfolio. Also, within upper extremities business, the company saw solid demand for a comprehensive shoulder line.
In this regard, we note that since last November, the company has received several FDA clearances within S.E.T. and is particularly, excited about the approval of the Sidus Stem-Free Shoulder system. We expect all these developments to significantly contribute to the company’s top line in the first quarter itself.
Zimmer Biomet Holdings, Inc. Price and EPS Surprise
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.